M Ventures by Merck

What is M Ventures by Merck?

M Ventures is the strategic corporate venture capital arm of the science and technology company Merck KGaA based in Darmstadt, Germany. Stationed in Amsterdam, Noord-Holland, The Netherlands, M Ventures specializes in seeding transformative ideas and has been operational since its inception in 2009.

With a considerable fund allocation of €600 million, the firm has made over 100 investments, positioning itself as entrepreneurs at heart in both biotechnology and technology sectors. M Ventures primarily explores opportunities within biotechnology, focusing on novel approaches to challenging diseases and disruptive R&D and manufacturing technologies.

In the technology domain, M Ventures seeks to shape the future by investing in startups that innovate in computing, data storage, display technologies, and digital transformation, while also tackling complex challenges at the intersection of sustainability and technology convergence.

M Ventures backs companies that display the potential to impact healthcare drug development, life science tools, electronics, and frontier technologies.

The fund operates with a dual strategic and financial focus, aiming to add value through an active engagement model. M Ventures collaborates closely with entrepreneurs and co-investors, fostering a supportive environment aimed at commercial success.

Testimonials from CEOs of various portfolio companies assert the fund's hands-on approach when necessary, founder-friendly nature, and the tangible business value they add. The fund's portfolio encompasses varied successes, including immunotherapy biotech company Calypso Biotech, semiconductor company MemryX, novel therapeutics developer Outrun Therapeutics, and metasurface tech innovator Metalenz.

M Ventures commits to asking the hard questions that address pressing, worth-solving problems and actively supports the growth and scaling of the innovative companies in its investment portfolio.